Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
| العنوان: | Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium |
|---|---|
| المؤلفون: | Etsuro Mori, Daniel Weintraub, Pietro Tiraboschi, Bradley F. Boeve, David J. Burn, Masahito Yamada, Debby W. Tsuang, Glenda M. Halliday, David P. Salmon, Omar M. A. El-Agnaf, James B. Leverenz, Pamela J. McLean, Melissa E. Murray, Owen A. Ross, Stephen N. Gomperts, Kenji Kosaka, Laura Bonanni, Simon J.G. Lewis, Alan Thomas, Lawrence S. Honig, Ashley Bayston, Dennis W. Dickson, Daniel I. Kaufer, Nicolaas Bohnen, John E. Duda, Ronald B. Postuma, Jon B. Toledo, Zuzana Walker, Dag Aarsland, Jose Bras, Andrew B. Singleton, Johannes Attems, Tanis J. Ferman, Alice Chen-Plotkin, Virginia M.Y. Lee, Carol F. Lippa, John T. O'Brien, Thomas G. Beach, Alex Iranzo, Hiroshige Fujishiro, Angela Lunde, Frédéric Blanc, Dominic Ffytche, Ian G. McKeith, Clive Ballard, James E. Galvin, Patrik Brundin, Angela Taylor, Emilio Moreno, Brit Mollenhauer, Thomas J. Montine, Neill R. Graff-Radford, M Masellis, Shankar Ramaswamy, Jennifer G. Goldman, Eliezer Masliah, John Q. Trojanowski, Howard Feldman, Sotoshi Orimo, Douglas Galasko, John-Paul Taylor, Kejal Kantarci, Walter Kukull |
| المساهمون: | O'Brien, John [0000-0002-0837-5080], Apollo - University of Cambridge Repository, Laboratoire des sciences de l'ingénieur, de l'informatique et de l'imagerie (ICube), École Nationale du Génie de l'Eau et de l'Environnement de Strasbourg (ENGEES)-Université de Strasbourg (UNISTRA)-Institut National des Sciences Appliquées - Strasbourg (INSA Strasbourg), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de Recherche en Informatique et en Automatique (Inria)-Les Hôpitaux Universitaires de Strasbourg (HUS)-Centre National de la Recherche Scientifique (CNRS)-Matériaux et Nanosciences Grand-Est (MNGE), Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Réseau nanophotonique et optique, Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS) |
| المصدر: | Neurology Neurology, vol 89, iss 1 Neurology, 2017, 89 (1), pp.88-100. ⟨10.1212/WNL.0000000000004058⟩ McKeith, I G, Boeve, B F, DIckson, D W, Halliday, G, Taylor, J P, Weintraub, D, Aarsland, D, Galvin, J, Attems, J, Ballard, C G, Bayston, A, Beach, T G, Blanc, F, Bohnen, N, Bonanni, L, Bras, J, Brundin, P, Burn, D, Chen-Plotkin, A, Duda, J E, El-Agnaf, O, Feldman, H, Ferman, T J, Ffytche, D, Fujishiro, H, Galasko, D, Goldman, J G, Gomperts, S N, Graff-Radford, N R, Honig, L S, Iranzo, A, Kantarci, K, Kaufer, D, Kukull, W, Lee, V M Y, Leverenz, J B, Lewis, S, Lippa, C, Lunde, A, Masellis, M, Masliah, E, McLean, P, Mollenhauer, B, Montine, T J, Moreno, E, Mori, E, Murray, M, O'Brien, J T, Orimo, S, Postuma, R B, Ramaswamy, S, Ross, O A, Salmon, D P, Singleton, A, Taylor, A, Thomas, A, Tiraboschi, P, Toledo, J B, Trojanowski, J Q, Tsuang, D, Walker, Z, Yamada, M & Kosaka, K 2017, ' Diagnosis and management of dementia with Lewy bodies : Fourth consensus report of the DLB Consortium ', Neurology, vol. 89, no. 1, pp. 88-100 . https://doi.org/10.1212/WNL.0000000000004058Test |
| بيانات النشر: | Ovid Technologies (Wolters Kluwer Health), 2017. |
| سنة النشر: | 2017 |
| مصطلحات موضوعية: | 0301 basic medicine, Lewy Body Disease, medicine.medical_specialty, Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC], Consensus, [SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging, Clinical Sciences, Disease, REM sleep behavior disorder, law.invention, 03 medical and health sciences, 0302 clinical medicine, Neuroimaging, Randomized controlled trial, law, mental disorders, medicine, Humans, Intensive care medicine, Psychiatry, Neurology & Neurosurgery, Views & Reviews, Dementia with Lewy bodies, business.industry, Neurosciences, medicine.disease, 3. Good health, Clinical trial, 030104 developmental biology, [SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health, Practice Guidelines as Topic, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Cognitive Sciences, Dementia, Lewy Bodies, Neurology (clinical), Alzheimer's disease, business, Neurocognitive, 030217 neurology & neurosurgery, Biomarkers |
| الوصف: | The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade. The revised DLB consensus criteria now distinguish clearly between clinical features and diagnostic biomarkers, and give guidance about optimal methods to establish and interpret these. Substantial new information has been incorporated about previously reported aspects of DLB, with increased diagnostic weighting given to REM sleep behavior disorder and 123iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy. The diagnostic role of other neuroimaging, electrophysiologic, and laboratory investigations is also described. Minor modifications to pathologic methods and criteria are recommended to take account of Alzheimer disease neuropathologic change, to add previously omitted Lewy-related pathology categories, and to include assessments for substantia nigra neuronal loss. Recommendations about clinical management are largely based upon expert opinion since randomized controlled trials in DLB are few. Substantial progress has been made since the previous report in the detection and recognition of DLB as a common and important clinical disorder. During that period it has been incorporated into DSM-5, as major neurocognitive disorder with Lewy bodies. There remains a pressing need to understand the underlying neurobiology and pathophysiology of DLB, to develop and deliver clinical trials with both symptomatic and disease-modifying agents, and to help patients and carers worldwide to inform themselves about the disease, its prognosis, best available treatments, ongoing research, and how to get adequate support. |
| وصف الملف: | application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| اللغة: | English |
| تدمد: | 0028-3878 1526-632X |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4de7346ee0ae89783c2531c527f5bdfcTest https://www.repository.cam.ac.uk/handle/1810/264965Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....4de7346ee0ae89783c2531c527f5bdfc |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 00283878 1526632X |
|---|